Professional Documents
Culture Documents
Carling, MD
Professor of Clinical Medicine,
Boston University School of Medicine
APUA Webinar
July 2, 2013
How the problem developed
Four Elements:
1. Measure IV antibiotic use
2. Optimize IV to oral switch
3. Teach the core concepts of antibiotic use
4. Measure success and escalate the program
2
Sir Alexander Fleming
3
Achieve optimal clinical outcomes
Minimize toxicity and other adverse events
Minimize development of antimicrobial resistance
4
5
6
7
8
9
What would Duke have
said about our nave
optimism about
antibiotic use over the
past 60 years?
10
11
12
13
Coming to a
hospital near you!
14
9 Isolates
K. pneumoniae (5), E. coli (2), Enterobacter cloacae (1),
Salmonella (1)
Resistant to all lactams + carbenipenems,
all aminoglycosides, all quinolones
Colistin sens. Tygecycline variable
All isolates also carried other resistance genes
15
18
16
14
12
10
8
6
4
2
0
1983-1987 1988-1992 1993-1997 1998-2002 2003-2007 2008-2011
16
Only 15-16 antibiotics are in development
Only 8 of these have activity against key Gram negative
bacteria
None have activity against bacteria resistant to all current
drugs
17
FDA Review
Phase III
Phase II
Phase 1
Pre-clinical
0 1 2 3 4 5 6 7 8 9 10
Discovery
18
March 2010 | Volume 58
Editorial
http://www.japi.org/march_2010/article_01.html
19
21
You can achieve incredible progress if you
set a clear goal and find a measure that will
drive progress toward that goal.
24
600
Hundred thousand dollars
550
500
450
400
1988 1989 1990
26
The equation was
simple
A. More expensive antibiotics
were being used.
B. Costs were going down.
27
28
29
The hospital was
shrinking!!
30
DDD/1000 PTD
31
30
Defined Dose Days / 1000 PT DAYS
25
20
15
10
> 200 % increase
5
32
5
0
PERCENT CHANGE
-5
-10
-15
-20
1991 1992 1993
DDD / 1000 PT DAYS COST / 1000 PT DAYS MEDICARE CASE MIX INDEX
33
Impact of the Program
20
10
PERCENT CHANGE
-10
-20
-30
-40
1991 1992 1993 1994 1995 1996 1997 1998
DDD / 1000 PT DAYS COST / 1000 PT DAYS MEDICARE CASE MIX INDEX
34
ANTIBIOTIC COSTS / 1000 PT DAYS
40 IN 14 ACUTE CARE HOSPITALS
30
20
10
Percent
-10
-20
-30
-40
A B C D E F G H I J K L M N
GROUP A GROUP B
36
Four Elements:
1. Measure IV antibiotic use
2. Optimize IV to oral switch
A. Pick the low-hanging fruit
B. IV treatment is not needed
3. Teach the core concepts of antibiotic use
A. Dont treat unnecessarily
B. Higher dose shorter duration
C. Consult ID early and often
4. Measure success and escalate the program
Linezolid
Empiric use varies between hospitals
PO = IV blood levels
Both cost > $200. / day
IV is more costly
39
B. IV treatment is not needed
PO often very effectiveespecially when you dont
really need to continue antibiotic therapy
40
B. IV treatment is not needed
Bad news:
It takes work, education and some time (varies)
41
Four Elements:
1. Measure IV antibiotic use
2. Optimize IV to oral switch
3. Teach the core concepts of antibiotic use
A. Dont treat unnecessarily
B. Higher dose shorter duration
C. Consult ID early and often
4. Measure success and escalate the program
43
Most Common Reasons for
Unnecessary Days of Therapy
150
94
100
50
0
Duration of therapy Noninfectious or Treatment of
longer than nonbacterial colonization or
necessary syndrome contamination
45
A. Dont treat unnecessarily
Empiric treatment should be for evident serious
infection in hospitalized patients.pneumonia,
occult sepsis, documented meningitis, urosepsis.
CASE STUDY
46
56 y.o. man, no meds, moderate alcohol, smoker
1wk. - fevers, myalgias, cough
3d. - PCP visit 102 fever, CXR ? +, moderate diarrhea
Rxd - Levofloxacin
1d. - Fever to 103, worse SOB
PE - 103.4, R 32, Toxic appearing
- Chest - Poor breath sounds RA SaO2 82%
- WBC 10.7 - 82p 15B
- Na+ 127 k+ 3.4 Cl- - 85 HC03 25.6
- Cr 1.4 UA SG 1.30, 5-10 WBC, 10-15 RBC
47
48
Differential Diagnosis Extensive
Viral pneumonia Influenza, Adenovirus Rhinovirus, Severe sepsis
with evolving respiratory failure
Evolving bacterial pneumonia on top of preceding viral pneumonia
Legionnaire's disease
Pneumocystis pneumonia
New Coronavirus (SARS)
Antibiotic Therapy
Ticaricillin-sulbactam, Levofloxacin,Tamiflu and bactrim
49
Course
Intubated with
progressive pneumonia
x6d
ARF necessitating
dialysis x2 wk.
Gradual Improvement
D/C after 3wk.
hospitalization
50
Your Answer?
51
Your Answer?
52
A. Dont treat unnecessarily
Empiric treatment should be for evident serious
infection in hospitalized patients.pneumonia,
occult sepsis, documented meningitis, urosepsis.
53
B. Think - Higher dose Shorter duration
Higher doses are safewith exceptions
Continuous IV Rx Beta Lactams gaining acceptance
Shorter Duration
CAP 3d. = 8d.
VAP 8d. = 15d.
Cellulitis 5d. = 10d.
Cystitis 3 to 5d. Fine in many studies
Pyelonephritis 5 to 7 d.
54
C. Consult ID early and often
Providers who try to use antibiotics need support!
Share the worry
Different perspectives are valuable
Education is pragmatic not didactic
Provides for next step planning of treatment
Share the liability risk
It is CHEAP
the cost of a dose of newer IV antibiotics
55
Four Elements:
1. Measure IV antibiotic use
2. Optimize IV to oral switch
3. Teach the core concepts of antibiotic use
A. Dont treat unnecessarily
B. Higher dose shorter duration
C. Consult ID early and often
57
Questions Comments? Philip.Carling.MD@steward.org
58